These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2833202)

  • 1. Identification of the pseudorabies virus glycoprotein gp50 as a major target of neutralizing antibodies.
    Eloit M; Fargeaud D; L'Haridon R; Toma B
    Arch Virol; 1988; 99(1-2):45-56. PubMed ID: 2833202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudorabies virus glycoprotein gIII is a major target antigen for murine and swine virus-specific cytotoxic T lymphocytes.
    Zuckermann FA; Zsak L; Mettenleiter TC; Ben-Porat T
    J Virol; 1990 Feb; 64(2):802-12. PubMed ID: 2153244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping and characterization of neutralizing epitopes of glycoproteins gIII and gp50 of the Indiana-Funkhauser strain of pseudorabies virus.
    Coe NE; Mengeling WL
    Arch Virol; 1990; 110(1-2):137-42. PubMed ID: 1689995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of glycoproteins of pseudorabies virus in eliciting neutralizing antibodies.
    Ben-Porat T; DeMarchi JM; Lomniczi B; Kaplan AS
    Virology; 1986 Oct; 154(2):325-34. PubMed ID: 2429441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection from pseudorabies virus challenge in mice by a combination of purified gII, gIII and gVI antigens.
    Matsuda Tsuchida A; Katayama S; Okada N; Okabe T; Sasaki N
    J Vet Med Sci; 1992 Jun; 54(3):447-52. PubMed ID: 1322712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of protective immunity and neutralizing antibodies to pseudorabies virus by immunization of anti-idiotypic antibodies.
    Tsuda T; Onodera T; Sugimura T; Murakami Y
    Arch Virol; 1992; 124(3-4):291-300. PubMed ID: 1318708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-transmissible pseudorabies virus gp50 mutants: a new generation of safe live vaccines.
    Peeters B; Bouma A; de Bruin T; Moormann R; Gielkens A; Kimman T
    Vaccine; 1994 Mar; 12(4):375-80. PubMed ID: 8178562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycoprotein gp50-negative pseudorabies virus: a novel approach toward a nonspreading live herpesvirus vaccine.
    Heffner S; Kovács F; Klupp BG; Mettenleiter TC
    J Virol; 1993 Mar; 67(3):1529-37. PubMed ID: 8382308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and mapping of a nonessential pseudorabies virus glycoprotein.
    Wathen MW; Wathen LM
    J Virol; 1986 Apr; 58(1):173-8. PubMed ID: 3005646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of several pseudorabies viral strains by virus-neutralization test using monoclonal antibodies.
    Nosetto EO; Echeverria MG; Horimoto T; Pecoraro MR; Galosi CM; Tohya Y; Norimine J; Takahashi E; Etcheverrigaray ME; Mikami T
    Viral Immunol; 1997; 10(3):159-64. PubMed ID: 9344338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudorabies virus glycoprotein gI: in vitro and in vivo analysis of immunorelevant epitopes.
    Fuchs W; Rziha HJ; Lukàcs N; Braunschweiger I; Visser N; Lütticken D; Schreurs CS; Thiel HJ; Mettenleiter TC
    J Gen Virol; 1990 May; 71 ( Pt 5)():1141-51. PubMed ID: 1693164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a recombinant vaccinia virus containing pseudorabies (PR) virus glycoprotein genes gp50, gII, and gIII as a PR vaccine for pigs.
    Mengeling WL; Brockmeier SL; Lager KM
    Arch Virol; 1994; 134(3-4):259-69. PubMed ID: 8129615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early interactions of pseudorabies virus with host cells: functions of glycoprotein gIII.
    Zuckermann F; Zsak L; Reilly L; Sugg N; Ben-Porat T
    J Virol; 1989 Aug; 63(8):3323-9. PubMed ID: 2545907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of mice and swine from pseudorabies virus conferred by vaccinia virus-based recombinants.
    Riviere M; Tartaglia J; Perkus ME; Norton EK; Bongermino CM; Lacoste F; Duret C; Desmettre P; Paoletti E
    J Virol; 1992 Jun; 66(6):3424-34. PubMed ID: 1316458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of mice and swine from pseudorabies virus-induced mortality by administration of pseudorabies virus-specific mouse monoclonal antibodies.
    Marchioli C; Yancey RJ; Timmins JG; Post LE; Young BR; Povendo DA
    Am J Vet Res; 1988 Jun; 49(6):860-4. PubMed ID: 2840843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of complement-independent neutralizing epitopes on pseudorabies virus glycoprotein gp50.
    Tsuda T; Yamada S; Murakami Y; Sugimura T
    J Vet Med Sci; 1991 Jun; 53(3):533-5. PubMed ID: 1715760
    [No Abstract]   [Full Text] [Related]  

  • 17. Production and characterization of monoclonal antibodies directed against pseudorabies virus.
    Wathen LM; Platt KB; Wathen MW; Van Deusen RA; Whetstone CA; Pirtle EC
    Virus Res; 1985 Dec; 4(1):19-29. PubMed ID: 3002067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of antibodies to pseudorabies virus by immunization with antiidiotypic antibodies.
    Gurish MF; Ben-Porat T; Nisonoff A
    Ann Inst Pasteur Immunol; 1988; 139(6):677-87. PubMed ID: 2849957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccine.
    Eloit M; Gilardi-Hebenstreit P; Toma B; Perricaudet M
    J Gen Virol; 1990 Oct; 71 ( Pt 10)():2425-31. PubMed ID: 2172456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of pseudorabies virus glycoprotein B expressed by canine herpesvirus.
    Nishikawa Y; Xuan X; Kimura M; Otsuka H
    J Vet Med Sci; 1999 Oct; 61(10):1113-7. PubMed ID: 10563288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.